First, controlling the expression of PD-L1, TIGIT, and other biomarkers, as well as the quantity and quality of TILs, circulating tumor cells, and TAMs, can affect tumor invasion, metastasis, and recurrence in various patient populations [198, 199]. The gene discussed is CD274; the disease is neoplasm.